Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives $11.77 Consensus Target Price from Analysts
Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the sixteen brokerages that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have issued a buy rating and […]
12 Sep 01:58 · The Cerbat Gem